HMOX1 and diabetic kidney disease: Butyrate uses the Nrf2/HO-1 pathway to ameliorate diabetic nephropathy [56], to regulate Th17/Treg cell balance [57] and to protects against high-fat diet-induced oxidative stress in rat liver [58].